AU5778399A - Gene therapy for treatment of cancer - Google Patents

Gene therapy for treatment of cancer

Info

Publication number
AU5778399A
AU5778399A AU57783/99A AU5778399A AU5778399A AU 5778399 A AU5778399 A AU 5778399A AU 57783/99 A AU57783/99 A AU 57783/99A AU 5778399 A AU5778399 A AU 5778399A AU 5778399 A AU5778399 A AU 5778399A
Authority
AU
Australia
Prior art keywords
cancer
treatment
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57783/99A
Other languages
English (en)
Inventor
Yi Lu
Mitchell S. Steiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENOTHERAPEUTICS Inc
Original Assignee
GENOTHERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENOTHERAPEUTICS Inc filed Critical GENOTHERAPEUTICS Inc
Publication of AU5778399A publication Critical patent/AU5778399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y106/00—Oxidoreductases acting on NADH or NADPH (1.6)
    • C12Y106/02—Oxidoreductases acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12Y106/02004—NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU57783/99A 1998-09-04 1999-09-03 Gene therapy for treatment of cancer Abandoned AU5778399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14827598A 1998-09-04 1998-09-04
US09148275 1998-09-04
PCT/US1999/018834 WO2000014256A1 (fr) 1998-09-04 1999-09-03 Therapie genique pour le traitement du cancer

Publications (1)

Publication Number Publication Date
AU5778399A true AU5778399A (en) 2000-03-27

Family

ID=22525057

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57783/99A Abandoned AU5778399A (en) 1998-09-04 1999-09-03 Gene therapy for treatment of cancer

Country Status (2)

Country Link
AU (1) AU5778399A (fr)
WO (1) WO2000014256A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207648B1 (en) 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
GB0216203D0 (en) * 2002-07-12 2002-08-21 Imp Cancer Res Tech Mondulation of cytochrome P450 reductase activity
US7700822B2 (en) 2002-07-12 2010-04-20 Cancer Research Technology Limited Modulation of cytochrome P450 reductase activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6207648B1 (en) * 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy

Also Published As

Publication number Publication date
WO2000014256A1 (fr) 2000-03-16

Similar Documents

Publication Publication Date Title
AU5089799A (en) Drug complex for treatment of metastatic prostate cancer
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU3891299A (en) Combination therapy for treatment of depression
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
EP1176964B8 (fr) Utilisation du compose et743 pour le traitement du cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU3704800A (en) Co-administration of lucanthone and radiation for treatment of cancer
AU2001268467A1 (en) Identification of genes and compounds for treatment of cancer
AU3784999A (en) Methods for treatment of pain
AU5300396A (en) Radiation enhanced gene therapy for treatment of tumors
AU3082401A (en) Therapy of psoriasis
AU4369800A (en) Treatment of metastatic cancer through mts-1 gene
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU5241499A (en) Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU1979499A (en) Apparatus for therapeutic electromagnetic treatment
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU5778399A (en) Gene therapy for treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
GB9819999D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase